Phosphorylation of Nucleoside Analogues by Deoxycytidine Kinase
Aim: Characterization of substrate properties (Km and Vmax) of new nucleoside analogues for human deoxycytidine kinase in comparison with the properties of known nucleoside analogues (e.g. aracytidine, gemcitabine, cladribine and lamivudine).
Deoxycytidine kinase (dCK) enzyme: The dCK used in the assays is a human recombinant dCK, cloned from human cells, expressed in E. coli, produced and purified by NOVOCIB (click here for details). The enzyme purity is controlled by SDS-PAGE. Protein concentration is measured by Bradford method (Bio-Rad). dCK enzymatic activity (≥ 0.025 unit/mg protein) is systematically controlled before performing any assay.
(^Top)
| Substrate | NovoCIB | Published data | ||||
| Km (µM) | Vmax
(µmol/mg/min) |
Relative Vmax
(% of dCR) |
Km (µM) | Vmax
(µmol/mg/min) |
Ref | |
| Deoxycytidine | 0.577 | 0.026 | 100 | 0.16 | 0.033 | Recombinant, Johansson Karlsson 1995 |
| 1.3 | 0.069 | Recombinant, Usova & Eriksson, 1997 |
||||
| 0.57 | 0.004 | Partially purified, Someya H. et al 2003 |
||||
| Gemcitabine (dFdC) | 42.71 | 0.325 | 1250 | |||
| Deoxyadenosine | 150.5 | 1.08 | 4153 | 115 | Recombinant, Sabini E. et al 2008 |
|
| 480 | 1.5 | Recombinant, Johansson Karlsson 1995 |
||||
| Aracytidine (AraC) | 6.81 | 0.224 | 862 | 15 | 0.009 | Partially purified, Someya H. et al 2003 |
| Cladribine | 56.5 | 0.285 | 1096 | 89 | 0.126 | Recombinant, Usova & Eriksson, 1997 |
| 24 | 0.76 | Recombinant, Johansson Karlsson 1995 |
||||
Deoxycytidine kinase (dCK) enzyme: The dCK used in the assays is a human recombinant dCK, cloned from human cells, expressed in E. coli, produced and purified by NOVOCIB (click here for details). The enzyme purity is controlled by SDS-PAGE. Protein concentration is measured by Bradford method (Bio-Rad). dCK enzymatic activity (≥ 0.025 unit/mg protein) is systematically controlled before performing any assay.
V mouse over to enlarge
![]() Kinetics Analysis: Enzymatic activity of deoxycytidine kinase with particular nucleoside substrate is measured continuously by spectrophotometric assays in a coupled lactate dehydrogenase/pyruvate kinase system. Assays are carried out at 37°C, at 50mM Tris-HCl pH7,6; 50mM KCl, 10mM MgCl2, 5mM ATP, 0,1mM NADH, 1mM phosphoenolpyruvate, 1mM DTT, PK 10U/ml, LDH 15U/ml, 0,9µM dCK. The nucleosides, nucleotides, LDH and PK are purchased from Sigma-Aldrich. Reaction is followed in an iEMS Reader MF (Labsystems) microtiter plate reader at 340nm. Assays are performed in duplicate (2 wells per compound and per concentration). Triplicates are available upon request. Km and Vmax are calculated from spectroscopic data using Michaelis-Menten equation. A confirmation by HPLC analysis of formation of monophosphorylated forms is available upon request. |
Download this document "dCK nucleoside phosphorylation assay"
To evaluate Nucleoside Analogues as potential IMPDH inhibitors, see also our
Nucleoside Kinase - IMPDH coupled assay
Nucleoside Kinase - IMPDH coupled assay
Ask for Quotation
To know more about our catalogue of Nucleoside kinases.




